| 000 | 01017 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513095803.0 | ||
| 264 | 0 | _c19961017 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(05)65106-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlaszyk, H | |
| 245 | 0 | 0 |
_aEvidence for diverse mutagens in breast cancer. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cSep 1996 |
||
| 300 |
_a683-4 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMutagens _xadverse effects |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xdrug effects |
| 700 | 1 | _aHartmann, A | |
| 700 | 1 | _aLiao, D Z | |
| 700 | 1 | _aKovach, J S | |
| 700 | 1 | _aSommer, S S | |
| 773 | 0 |
_tLancet (London, England) _gvol. 348 _gno. 9028 _gp. 683-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(05)65106-9 _zAvailable from publisher's website |
| 999 |
_c8779501 _d8779501 |
||